Fate Therapeutics, Inc. (NASDAQ:FATE) Insider Sells $18,768.

Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) insider Brian T. Powl sold 3,854 shares of the firm’s stock in a transaction dated Wednesday, July 5th. The stock was sold at an average price of $4.87, for a total value of $18,768.98. Following the transaction, the insider now owns 41,146 shares of the company’s stock, valued […]

Related Keywords

Canada , Stifel Nicolaus , Briant Powl , Financial Services Group Inc , Fate Therapeutics Inc , Nasdaq , Wells Fargo Company , Fate Therapeutics Company Profile , Securities Exchange Commission , Cantor Fitzgerald , Hightower Advisors , Royal Bank , Fate Therapeutics , Free Report , Exchange Commission , Services Group , Sigma Advisers , Tower Advisors , Wells Fargo , Fate Therapeutics Daily ,